Novel Antibacterial Surfaces

At a Glance

Researchers at Colorado State University have developed a composite antibacterial material that reduces bacterial attachment by up to 85%. The material combines a metal-organic framework (MOF) with a biopolymer film to create a passive, long-lasting antibacterial surface. It prevents early-stage biofilm formation without relying on antibiotics. The coating remains effective over repeated use, making it suitable for clinical environments.

Background

Biofilm formation is a major challenge in clinical environments because bacteria embedded in biofilms exhibit significantly increased resistance to antibiotics and host immune responses. Gram-negative organisms such as Pseudomonas aeruginosa are particularly problematic due to their ability to rapidly colonize surfaces and form structured biofilms. The initial stages of biofilm development involve bacterial adhesion, which is a critical step that determines subsequent biofilm growth and persistence. Conventional antimicrobial strategies typically target planktonic bacteria and are less effective once biofilms are established. Therefore, materials that can inhibit or disrupt early-stage bacterial attachment represent a promising strategy for preventing biofilm formation at its source.

Overview

This technology consists of a hybrid composite material that integrates a water-stable metal-organic framework (MOF) within a chitosan-based polymer film. The MOF serves as a functional component capable of facilitating controlled release of bioactive species, such as nitric oxide donors, while the chitosan matrix provides a biocompatible and structurally stable substrate. The interaction between these components creates a surface environment that interferes with bacterial adhesion mechanisms, including surface attachment and early colonization.

Experimental evaluation using cellular viability and adhesion assays demonstrated an approximately 85% reduction in Pseudomonas aeruginosa attachment over a 24-hour period. Importantly, the material maintained its antibacterial performance across multiple experimental cycles, indicating sustained activity and potential for reuse. By targeting the adhesion phase of the biofilm life cycle, this material functions as a passive antimicrobial surface, reducing the likelihood of biofilm establishment without relying on continuous antibiotic exposure or active intervention.

Cellular viability of attached P. aeruginosa bacteria onto polystyrene wells (PC = positive control), chitosan, and chitosan/Cu-BTTri films (at 1%, 5%, 10%, and 20% w/w MOF incorporation) after exposure for 6 and 24 h as determined by CellTiter Blue assay. Average and 95% confidence interval displayed, n = 6. Statistically significant differences between cellular viabilities are indicted (*) and not statistically significant differences are indicated by (ns) as determined by a one-way ANOVA.

Benefits

The material reduces bacterial attachment by approximately 85%, significantly limiting early-stage biofilm formation.
It prevents biofilm development by targeting bacterial adhesion before colonies can establish.
The surface provides passive antibacterial protection without requiring active dosing or external intervention.
The material maintains its effectiveness over multiple uses, indicating durability and reusability.
It can be applied as a coating and integrated into existing medical devices and surfaces.